Multicenter, Phase III, Randomized, Open Label Study to Evaluate the Efficacy and Safety of a Fixed-dose Combination of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD).
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Formoterol/fluticasone propionate; Salmeterol/fluticasone propionate
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 18 Oct 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 15 Jul 2011 New trial record